All In MedTech

Device Trial Radar · NCT02533531

Proof of Concept Study for 1 Lead Patch Technology

Last checked: Nov 20, 2026Latest source record: Apr 6, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

1

Actual

Start

Apr 16, 2014

Primary completion

Jun 9, 2016

Study completion Jun 9, 2016

Sponsor

Lead sponsor
LifeWatch Services, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 26, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is intended to assess the feasibility and usability of the 1 Lead Patch as a whole, on patients outside the hospital, in the out-patient setting.

Conditions

  • Telemetry

Interventions

  • 1-Lead PatchDevice

    The 1-Lead Patch will record and transmit ECG data to a gateway, which will then transmit the data to a central database.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite Outcome Measure - 100% Successful ECG AcquisitionTime frame: Between 7 and 14 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mt. Sinai Medical Center

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.